scholarly journals Phase I trial of exemestane in combination with metformin and rosiglitazone in nondiabetic obese postmenopausal women with hormone receptor–positive metastatic breast cancer

2012 ◽  
Vol 71 (1) ◽  
pp. 63-72 ◽  
Author(s):  
Francisco J. Esteva ◽  
Stacy L. Moulder ◽  
Ana M. Gonzalez-Angulo ◽  
Joe Ensor ◽  
James L. Murray ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase I ◽  
Postmenopausal Women ◽  
Hormone Receptor ◽  
Phase I Trial ◽  
Metastatic Breast ◽  
Hormone Receptor Positive

Phase I/II study of letrozole and sorafenib as first-line therapy of hormone-receptor positive (HR+) metastatic breast cancer (MBC).

2014 ◽  
Vol 32 (15_suppl) ◽  
pp. 531-531
Author(s):  
Antoinette R. Tan ◽  
Serena Tsan-Lai Wong ◽  
Robert D. Warren ◽  
Jennifer Eng-Wong ◽  
Minetta C. Liu ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase I ◽  
Hormone Receptor ◽  
Metastatic Breast ◽  
First Line ◽  
First Line Therapy ◽  
Hormone Receptor Positive ◽  
Line Therapy

scholarly journals Phase 1b study of orteronel in postmenopausal women with hormone-receptor positive (HR+) metastatic breast cancer

2016 ◽  
Vol 35 (1) ◽  
pp. 87-94 ◽  
Author(s):  
Murtuza Rampurwala ◽  
Kari B. Wisinski ◽  
Mark E. Burkard ◽  
Sima Ehsani ◽  
Ruth M. O’Regan ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Postmenopausal Women ◽  
Hormone Receptor ◽  
Metastatic Breast ◽  
Hormone Receptor Positive ◽  
Phase 1B

Phase 1b study of orteronel in postmenopausal women with hormone-receptor positive (HR+) metastatic breast cancer.

2014 ◽  
Vol 32 (15_suppl) ◽  
pp. 538-538 ◽  
Author(s):  
Murtuza M. Rampurwala ◽  
Mark E. Burkard ◽  
Kari Braun Wisinski ◽  
Sima Ehsani Chimeh ◽  
Jamie Zeal ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Postmenopausal Women ◽  
Hormone Receptor ◽  
Metastatic Breast ◽  
Hormone Receptor Positive ◽  
Phase 1B
Sign in / Sign up

Export Citation Format

Share Document